The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

enthalten in: Cancer Communications | 2019

von Guan, X. | Ma, F. | Li, C. | +13

Polymorphisms of MTHFR and TYMS predict capecitabine‐induced hand‐foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer Communications | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

The association between early‐onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple‐negative breast cancer patients and some novel autophagy‐related polymorphisms in their genomic DNA : a real‐world study

enthalten in: Cancer Communications | 2018

von Liu, B. | An, T. | Li, M. | +10